The Effect of Acipimox on GLP (Glucagon-like Peptide)-1 Secretion
NCT02796950
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Diabetes Mellitus Type 2
Interventions
DRUG:
Acipimox
Sponsor
University of Aarhus